Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
UPR.IR
BUYUniphar plc · Healthcare · Ireland · $1.4B · Avg Vol: $1M/d
71
StockRankGet insider-trade alerts
Q
53
V
49
M
62
P/E (TTM)
23.4x
ROE
12.7%
D/E
1.3x
Dividend %
0.4%
COMPANY DESCRIPTION
Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 2.4B | 2.9B | 3.2B | 3.5B | 14.1% | 3.5B | 3.6B | 3.8B | 4.6% |
| EPS | 0.20 | 0.19 | 0.19 | 0.27 | 0.22 | 2.5% | 0.22 | 0.23 | 0.25 | 6.3% |
| Shares | — | 273.0M | 273.0M | 273.0M | 259.6M | -4.9% | 259.6M | — | — | — |
| Debt | — | 358.5M | 434.5M | 462.0M | 583.2M | 17.6% | 583.9M | — | — | — |
| Equity | — | 329.4M | 378.6M | 457.0M | 460.7M | 11.8% | — | — | — | — |
| Op CF | — | 94.2M | 59.7M | 141.4M | 123.3M | 9.4% | 123.5M | — | — | — |
| Inv CF | — | -121.0M | -102.9M | -109.7M | -87.7M | — | — | — | — | — |
| Fin CF | — | 57.3M | 22.3M | -13.1M | 57.1M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)-8.5%
SMA 50SMA 200
Close
$4.93
RSI (14)
20.6
52W High
$5.66
From 52W High
0.9%
SCORE BREAKDOWN
Quality
53
ROIC
9.4%72.2
ROE
12.7%78.4
GP/Assets
25.9%59.6
Op. Margin
3.3%52.3
FCF/Assets
2.3%57.0
Piotroski
550.0
Int. Cover
4.0x48.8
D/E Ratio
1.27x10.9
Current Ratio
0.99x10.7
Value
49
P/E (TTM)
23.4x50.7
EV/EBITDA
13.9x49.4
P/FCF
28.9x45.0
P/B
2.9x46.4
P/S
0.4x95.0
Div Yield
0.4%9.3
Momentum
62
52W High %
87%81.9
RS 6M
15%84.0
SMA 50/200
1.14x85.3
EPS Rev 4W
-1.9%19.1
EPS Rev 12W
—N/A
EPS Improve
+48%53.4
Q Growth
-31%17.0
FUNDAMENTALS
Market Cap
$1.4B
P/E (Forward)
15.9x
Gross Margin
14.9%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of UPR.IR are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| UPR.IR | Uniphar plc(you) | $1.4B | 71 | BUY |
| PRGO | Perrigo Company plc | $1.4B | 51 | HOLD |
| GHRS | GH Research PLC | $1.9B | 35 | SELL |
| ALKS | Alkermes plc | $8.8B | 78 | BUY |
| COPN.SW | Cosmo N.V. | $1.4B | 19 | STRONG SELL |
| ICLR | ICON Public Limited Company | $12.8B | 59 | HOLD |
| AMRN | Amarin Corporation plc | $284M | 44 | HOLD |
| 0RGI.L | Cosmo Pharmaceuticals N.V. | $1.8B | 16 | STRONG SELL |
| PRTA | Prothena Corporation plc | $458M | 28 | SELL |
| JAZZ | Jazz Pharmaceuticals plc | $15.9B | 88 | STRONG BUY |
Peer medians: ROE -0.0% · P/E 48.0x · Gross margin 50.4%